Login / Signup

Novel genetic mutation associated with hyperphosphatemic familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome treated with denosumab: a case report.

G FabbricianiA ColombiniC MessinaG Adami
Published in: Reumatismo (2024)
In this case report, a novel N-acetylgalactosaminyltransferase 3 homozygous mutation (c.782 G>A; p.R261Q) associated with hyperphosphatemic familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome is described. The patient had elbow, pelvis, and lower limb pain and a hard mass in the hip and olecranon regions. Increased levels of inorganic phosphorus (Pi) and C-reactive protein were observed. After treating the patient with conventional drugs, we tested denosumab, which reduced but did not normalize the Pi.
Keyphrases
  • case report
  • lower limb
  • bone mineral density
  • early onset
  • chronic pain
  • giant cell
  • genome wide
  • neuropathic pain
  • dna methylation
  • spinal cord injury
  • total hip arthroplasty
  • newly diagnosed
  • spinal cord